Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX)
$0.67
+0.0159 ( +2.43% ) 32.5K
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Market Data
Open
$0.67
Previous close
$0.65
Volume
32.5K
Market cap
$2.67M
Day range
$0.66 - $0.68
52 week range
$0.57 - $12.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 10, 2024 |
10-q | Quarterly Reports | 71 | May 09, 2024 |
8-k | 8K-related | 13 | May 03, 2024 |
8-k | 8K-related | 13 | Apr 09, 2024 |
10-k | Annual reports | 86 | Mar 14, 2024 |
8-k | 8K-related | 15 | Mar 13, 2024 |
8-k | 8K-related | 22 | Mar 08, 2024 |
8-k | 8K-related | 14 | Mar 06, 2024 |
def | Proxies and info statements | 4 | Feb 27, 2024 |
pre | Proxies and info statements | 4 | Feb 13, 2024 |